IL13 and metabolic dysfunction-associated steatohepatitis: To investigate the gradual increase of MFB activation during NASH, we performed a whole transcriptome analysis of primary human HSC treated with IL-13, TGFβ-1, or TNF-α for 24 h (Figure 1A).